The Role of Biomarkers in HR-Positive/HER2-Negative Early Breast Cancer: From Clinical Analysis to Clinical Decisions
Feb 25, 2022
46:25
Episode Description
Watch this 4-part discussion with expert pathologists and oncologists on the latest strategies for biomarker testing and treatment planning.
Credit available for this activity expires: 2/24/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/968999?src=mkm_podcast_addon_968999
Proudly Supported by
Patrons of Health Podcast Library
Supporting Shows
